X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Results showed that TLC599 (Dexamethasone Sodium Phosphate), a proprietary BioSeizer, demonstrated statistically significantly greater reduction in WOMAC pain and function as well as VAS scores compared to placebo through 24 weeks.
Lead Product(s): Dexamethasone Sodium Phosphate
Therapeutic Area: Rheumatology Product Name: TLC599
Highest Development Status: Phase IIIProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 07, 2022
Details:
The partnership aims to support the TLC for the launch and commercialization of their lead product AmphoTLC (amphotericin B) in India. It will be indicated for the COVID-19-associated mucormycosis cases.
Lead Product(s): Amphotericin B
Therapeutic Area: Infections and Infectious Diseases Product Name: AmphoTLC
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Strides Pharma Science
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership March 19, 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
